RCKT R&D Expenses
Rocket Pharmaceuticals Inc · R&D Expenses
RCKT R&D Expenses
Latest reported$124.37Mperiod ending
RCKT TTM R&D Expenses ($5.59M → $124.37M)
TTM R&D Expenses
High-resolution chart · PNG
RCKT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 124,366,000 | |
| 137,527,000 | |
| 142,015,000 | |
| 150,025,000 | |
| 158,272,000 | |
| 160,406,000 | |
| 168,224,000 | |
| 172,611,000 | |
| 177,140,000 | |
| 183,731,000 | |
| 186,342,000 | |
| 194,635,000 | |
| 191,174,000 | |
| 181,147,000 | |
| 165,570,000 | |
| 147,694,000 | |
| 143,932,000 | |
| 127,106,000 | |
| 124,621,000 | |
| 143,497,000 | |
| 125,533,000 | |
| 117,734,000 | |
| 106,382,000 | |
| 70,013,000 | |
| 63,185,000 | |
| 60,443,000 | |
| 58,623,000 | |
| 67,635,000 | |
| 65,871,000 | |
| 62,654,000 | |
| 53,260,000 | |
| 30,234,000 | |
| 19,987,000 | |
| 12,839,000 | |
| 14,193,000 | |
| 23,032,000 | |
| 28,626,000 | |
| 31,467,000 | |
| 31,985,000 | |
| 28,411,000 | |
| 23,611,000 | |
| 19,100,000 | |
| 12,554,000 | |
| 7,572,000 | |
| 5,203,000 | |
| 5,111,000 | |
| 5,592,000 | |
| 6,247,000 |